Fundraising FoxBEVC — Full Portfolio
8 tracked investments · listed companies and verified rows first
Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team.
BiotechHealthtechSouth San Francisco, US
Kathleen Collins(Director)inLawrence Kong(Executive Officer)inRon Park(President & CEO)inFrancine Gregoire(Chief Scientific Officer)inPriya Parameswaran(Chief Business Officer)in
BoardJayson Punwani(Director)in
Co-investorsPivotal Life SciencesSR One Capital ManagementAbingworth
AIMATX operates an AI platform for materials discovery that predicts material properties and guides targeted experimentation to shorten research cycles.
AI & Machine LearningDeep TechNew Materials
Co-investorsBerkeley FrontierBow CapitalTyche Partners
Dextera Biosciences develops dexabodies, a therapeutic modality built from D-amino acids that resists degradation by natural enzymes while retaining antibody-like specificity in a compact format, and can be conjugated to payloads such as steroids or toxins for targeted delivery.
AI & Machine LearningBiotech
Dev Sidhu(SAB Chair & Co-founder)Gregory Went(CEO & Chairman)Kyle Landgraf(VP of Discovery Research)
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)inToby Passioura(Founder)inGlen McIntyre(Founder)Timothy Craven(Founder)
BoardCOREY GOODMAN(Director)inMATT HERSHENSON(Director)in
Co-investorsCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersAxial VCvenBio Global Strategic
Khemia Metals develops earth-abundant alloys intended to replace critical metals in battery production, aiming to make batteries lighter, cheaper, and more sustainable.
CleantechEnergyNew MaterialsSan Carlos, US
Helen Bergstrom(Executive Officer, Director)Brian Hardin(Executive Officer, Director)
BoardJoshua James(Director)David Schroeder(Director)
Co-investorsBaruch Future VenturesDangerous Ventures
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)
Co-investorsDolby Family VenturesSV Health InvestorsTwo Bear CapitalDementia Discovery FundKdT Ventures
PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
BiotechDigital HealthFemTechIndianapolis, US
Richard T. Kloos(Chief Medical Officer)inTimothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Founder)Isaac Ro(Director)inRisa Stack(Director)inEric Wang(Executive Officer)
Co-investorsBlue Venture FundsCatalio Capital Management, LPMountain Group CapitalSandbox Industries
Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells.
AI & Machine LearningBiotechDeep Tech
Co-investorsNFXPioneerStartXThe 23 FundKdT Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.